Results

Total Results: 518 records

Showing results for "resistance".

401. Disposition of Comments Report for Testing of CYP2C19 Variants and Platelet Reactivity for Guiding Antiplatelet Treatment (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/antiplatelet-treatment_disposition-comments.pdf
     September 25, 2013 - some patients showing no platelet response to clopidogrel administration (“nonresponsiveness” or “resistance … sensitivity refers to the minimum detectable level of the analyte and analytical specificity describes the resistance

402. Development of Harmonized Outcome Measures for Use in Patient Registries and Clinical Practice: Methods and Lessons Learned (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/white-paper-standardized-library_0.pdf
     February 01, 2019 - Development of Harmonized Outcome Measures for Use in Patient Registries and Clinical Practice: Methods and Lessons Learned Final Report Development of Harmonized Outcome Measures for Use in Patient Registries and Clinical Practice: Methods and Lessons Learned Final Report …

403. Draft Report - Pharmacologic and Nonpharmacologic Treatments for Posttraumatic Stress Disorder: An Update of the Evidence Base for the PTSD Trials Standardized Data Repository (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd4-update-draft-report.pdf
     October 01, 2022 - Draft Report - Pharmacologic and Nonpharmacologic Treatments for Posttraumatic Stress Disorder: An Update of the Evidence Base for the PTSD Trials Standardized Data Repository Draft Evidence Report Number xx Pharmacologic and Nonpharmacologic Treatments for Posttraumatic Stress Disorder: An Update of the Eviden…

404. Development of Harmonized Outcome Measures for Use in Patient Registries and Clinical Practice: Methods and Lessons Learned (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/white-paper-standardized-library.pdf
     February 01, 2019 - Development of Harmonized Outcome Measures for Use in Patient Registries and Clinical Practice: Methods and Lessons Learned Final Report Development of Harmonized Outcome Measures for Use in Patient Registries and Clinical Practice: Methods and Lessons Learned Final Report …

405. Methods White Paper: Improving the Utility of Evidence Synthesis for Decision Makers in the Face of Insufficient Evidence (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/improving-utility-evidence-synthesis-white-paper.pdf
     April 01, 2021 - Methods White Paper: Improving the Utility of Evidence Synthesis for Decision Makers in the Face of Insufficient Evidence Methods White Paper Improving the Utility of Evidence Synthesis for Decision Makers in the Face of Insufficient Evidence Methods White Paper Improving the Utility of Evidence Synthesis …

406. Retention Strategies for Medications for Addiction Treatment in Adults With Opioid Use Disorder: A Rapid Evidence Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/mat-retention-strategies-rapid-review-1.pdf
     August 01, 2020 - Retention Strategies for Medications for Addiction Treatment in Adults With Opioid Use Disorder: A Rapid Evidence Review Retention Strategies for Medications for Addiction Treatment in Adults With Opioid Use Disorder: A Rapid Evidence Review Rapid Evidence Product R Rapid Evidence Product Retention Strateg…

407. Disposition of Comments for CER 183 Tonsillectomy for OSDB (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/tonsillectomy-disposition-170415.pdf
     January 17, 2017 - defined the term in the report (“breathing difficulties during sleep including OSA and upper airway resistance

408. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/acs-pci-adjunctive-devices_executive.pdf
     December 01, 2011 - Distal protection during primary coronary intervention can preserve the index of microcirculatory resistance

409. Disposition of Comments Report for Prevention of Healthcare-Associated Infections (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/health-careassociated-infections_disposition-comments.pdf
     November 30, 2012 - of Antimicrobial Locks for Tunneled Hemodialysis Catheters on Bloodstream Infection and Bacterial Resistance

410. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1312.pdf
     January 01, 2016 - T2DM hyperglycemia is a result of insulin resistance or a diminished response to insulin. … relative insulin deficiency and may have an insulin secretory defect in conjunction with insulin resistance

411. Ace-Inhibitor-Arb-Update-Surveillance-160328 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-update-surveillance-160328.pdf
     March 28, 2016 - $a$long"term$treatment$with$aliskiren$ or$ramipril$on$structural$alterations$of$subcutaneous$small"resistance

412. Methods Research Report: Challenges in Conducting EPC Reviews of Behavior Change Interventions (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/behavior-change_research.pdf
     August 01, 2015 - Methods Research Report: Challenges in Conducting EPC Reviews of Behavior Change Interventions Methods Research Report Challenges in Conducting EPC Reviews of Behavior Change Interventions Methods Research Report Challenges in Conducting EPC Reviews of Behavior Change Interven…

413. Long-Term Drug Therapy and Drug Holidays for Osteoporotic Fracture Prevention (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/research-protocol-osteoporosis_2.pdf
     October 05, 2018 - Long-Term Drug Therapy and Drug Holidays for Osteoporotic Fracture Prevention 1 Evidence-based Practice Center Systematic Review Protocol Project Title: Long-term Drug Therapy and Drug Holidays for Osteoporotic Fracture Prevention Initial publication date: April 13, 2018 Amendment Date: October 5,…

414. Comparative Effectiveness Review Disposition of Comments Report (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/bundled-payments-quality-effects_disposition-comments.pdf
     August 24, 2012 - (The report states that ³new bundled payment systems faced significant initial resistance from providers²

415. Long-Term Drug Therapy and Drug Holidays for Osteoporotic Fracture Prevention | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/osteoporosis-fracture-prevention/research-protocol
     April 12, 2018 - Current Page Topic Timeline Aug. 15, 2017 Topic Initiated Apr. 12, 2018 Research Protocol Apr. 23, 2019 Systematic Review Long-Term Drug Therapy and Drug Holidays for Osteoporotic Fracture Prevention Research Protocol April 12, 2018 Download Main Document PDF 357.6 KB I. Background and Objectives for …

416. Conducting Quantitative Synthesis when Comparing Medical Interventions: AHRQ and the Effective Health Care Program (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/methodsguide_conductingquantitativesynthesis.pdf
     October 01, 2010 - Conducting Quantitative Synthesis when Comparing Medical Interventions: AHRQ and the Effective Health Care Program Methods Guide for Comparative Effectiveness Reviews Conducting Quantitative Synthesis When Comparing Medical Interventions: AHRQ and the Effective Health Care Program …

417. Disposition of Comments for CER 153 Non-Muscle-Invasive Bladder Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/bladder-cancer-non-muscle-invasive_disposition-comments.pdf
     October 27, 2015 - Disposition of Comments for CER 153 Non-Muscle-Invasive Bladder Cancer Comparative Effectiveness Review Disposition of Comments Report Research Review Title: Emerging Approaches to Diagnosis and Treatment of Non- Muscle-Invasive Bladder Cancer Draft review available for public comment from November …

418. Conducting Quantitative Synthesis when Comparing Medical Interventions: AHRQ and the Effective Health Care Program (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-quantitative-synthesis_methods.pdf
     October 01, 2010 - Conducting Quantitative Synthesis when Comparing Medical Interventions: AHRQ and the Effective Health Care Program Methods Guide for Comparative Effectiveness Reviews Conducting Quantitative Synthesis When Comparing Medical Interventions: AHRQ and the Effective Health Care Program …

419. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1406.pdf
     September 26, 2014 - T2DM hyperglycemia is a result of insulin resistance or a diminished response to insulin. … relative insulin deficiency and may have an insulin secretory defect in conjunction with insulin resistance

420. Insulin-Blood-Sugar-2010 Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/insulin-blood-sugar-2010_executive.pdf
     January 01, 2010 - characterized by hyperglycemia resulting from defects in insulin secretion from the pancreatic beta cells; resistance … for 90 to 95 percent of diabetes in the United States, is the result of a combination of insulin resistance